Last reviewed · How we verify
Dose of 0.5% Ropivacaine
Dose of 0.5% Ropivacaine is a Small molecule drug developed by Benaroya Research Institute. It is currently FDA-approved.
At a glance
| Generic name | Dose of 0.5% Ropivacaine |
|---|---|
| Sponsor | Benaroya Research Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Does the Common Practice of Adding Diluted Epinephrine in Tranverse Abdominal Plan Block to Ropivacaine Significantly Decrease the Peak Systemic Resorption of Ropivacaine? (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (PHASE3)
- Zynrelef Versus Adductor Canal Block (PHASE4)
- Dexamethasone vs Dexmedetomidine vs Combination as Adjuvants to Popliteal Sciatic Nerve Block in Children (NA)
- The Efficacy of Personalized Local Anesthetic Dosing Based on Ultrasound-Measured Nerve Cross-Sectional Area in Brachial Plexus Block: a Non-Inferiority Randomized Controlled Trial. (NA)
- The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair (PHASE4)
- Minimum Effective Dose of Ropivacaine 0.5% for Ultrasound-guided Interscalene Block Targeting the C7 Nerve Root in Hand and Forearm Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dose of 0.5% Ropivacaine CI brief — competitive landscape report
- Dose of 0.5% Ropivacaine updates RSS · CI watch RSS
- Benaroya Research Institute portfolio CI
Frequently asked questions about Dose of 0.5% Ropivacaine
What is Dose of 0.5% Ropivacaine?
Dose of 0.5% Ropivacaine is a Small molecule drug developed by Benaroya Research Institute.
Who makes Dose of 0.5% Ropivacaine?
Dose of 0.5% Ropivacaine is developed and marketed by Benaroya Research Institute (see full Benaroya Research Institute pipeline at /company/benaroya-research-institute).
What development phase is Dose of 0.5% Ropivacaine in?
Dose of 0.5% Ropivacaine is FDA-approved (marketed).
Related
- Manufacturer: Benaroya Research Institute — full pipeline
- Compare: Dose of 0.5% Ropivacaine vs similar drugs
- Pricing: Dose of 0.5% Ropivacaine cost, discount & access